Teva Pharmaceutical Industries (TEVA) Net Equity Issued and Repurchased (2015 - 2016)

Teva Pharmaceutical Industries (TEVA) posted quarterly Net Equity Issued and Repurchased of $329.0 million for Q1 2016, down 90.0% on a QoQ basis from $3.3 billion in Q4 2015.

Teva Pharmaceutical Industries (TEVA) Net Equity Issued and Repurchased (2015 - 2016) Analysis & Trends

Teva Pharmaceutical Industries (TEVA) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $329.0 million the latest figure, recorded in Q1 2016.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $329.0 million in Q1 2016, while the trailing twelve-month figure through Dec 2016 was $329.0 million (down 90.0% YoY) and the FY2016 annual result came in at $329.0 million, down 90.0% from the prior year.
  • Net Equity Issued and Repurchased retreated to $329.0 million in Q1 2016 per TEVA's latest filing, from $3.3 billion in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for TEVA reached as high as $3.3 billion in Q4 2015 and fell as low as $329.0 million in Q1 2016.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 500,000.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2016 329.00 Mn
Mar 31, 2016 329.00 Mn
Dec 31, 2015 3.29 Bn
Dec 31, 2015 3.29 Bn